U.S. Markets open in 2 hrs 28 mins

Hafary Holdings Limited (SGX:5VS) Earns A Nice Return On Capital Employed

Simply Wall St

Today we'll evaluate Hafary Holdings Limited (SGX:5VS) to determine whether it could have potential as an investment idea. Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires.

First up, we'll look at what ROCE is and how we calculate it. Then we'll compare its ROCE to similar companies. And finally, we'll look at how its current liabilities are impacting its ROCE.

What is Return On Capital Employed (ROCE)?

ROCE measures the 'return' (pre-tax profit) a company generates from capital employed in its business. All else being equal, a better business will have a higher ROCE. Overall, it is a valuable metric that has its flaws. Renowned investment researcher Michael Mauboussin has suggested that a high ROCE can indicate that 'one dollar invested in the company generates value of more than one dollar'.

So, How Do We Calculate ROCE?

The formula for calculating the return on capital employed is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

Or for Hafary Holdings:

0.073 = S$12m ÷ (S$244m - S$85m) (Based on the trailing twelve months to June 2019.)

Therefore, Hafary Holdings has an ROCE of 7.3%.

View our latest analysis for Hafary Holdings

Is Hafary Holdings's ROCE Good?

When making comparisons between similar businesses, investors may find ROCE useful. In our analysis, Hafary Holdings's ROCE is meaningfully higher than the 2.2% average in the Trade Distributors industry. I think that's good to see, since it implies the company is better than other companies at making the most of its capital. Aside from the industry comparison, Hafary Holdings's ROCE is mediocre in absolute terms, considering the risk of investing in stocks versus the safety of a bank account. Investors may wish to consider higher-performing investments.

The image below shows how Hafary Holdings's ROCE compares to its industry, and you can click it to see more detail on its past growth.

SGX:5VS Past Revenue and Net Income, October 25th 2019

Remember that this metric is backwards looking - it shows what has happened in the past, and does not accurately predict the future. ROCE can be misleading for companies in cyclical industries, with returns looking impressive during the boom times, but very weak during the busts. This is because ROCE only looks at one year, instead of considering returns across a whole cycle. You can check if Hafary Holdings has cyclical profits by looking at this free graph of past earnings, revenue and cash flow.

Do Hafary Holdings's Current Liabilities Skew Its ROCE?

Current liabilities include invoices, such as supplier payments, short-term debt, or a tax bill, that need to be paid within 12 months. Due to the way the ROCE equation works, having large bills due in the near term can make it look as though a company has less capital employed, and thus a higher ROCE than usual. To counteract this, we check if a company has high current liabilities, relative to its total assets.

Hafary Holdings has total liabilities of S$85m and total assets of S$244m. As a result, its current liabilities are equal to approximately 35% of its total assets. Hafary Holdings has a medium level of current liabilities, which would boost its ROCE somewhat.

Our Take On Hafary Holdings's ROCE

Despite this, its ROCE is still mediocre, and you may find more appealing investments elsewhere. Of course, you might also be able to find a better stock than Hafary Holdings. So you may wish to see this free collection of other companies that have grown earnings strongly.

I will like Hafary Holdings better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.